DK2300492T3 - Hidtil ukendt antiviralt peptid mod aviær influenza h9n2 - Google Patents

Hidtil ukendt antiviralt peptid mod aviær influenza h9n2

Info

Publication number
DK2300492T3
DK2300492T3 DK09762696.4T DK09762696T DK2300492T3 DK 2300492 T3 DK2300492 T3 DK 2300492T3 DK 09762696 T DK09762696 T DK 09762696T DK 2300492 T3 DK2300492 T3 DK 2300492T3
Authority
DK
Denmark
Prior art keywords
aviary
peptid
influenza
antiviral
unknown
Prior art date
Application number
DK09762696.4T
Other languages
Danish (da)
English (en)
Inventor
Khatijah Mohd Yusoff
Abdul Rahman Omar
Aini Ideris
Mohamed Rajik
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Application granted granted Critical
Publication of DK2300492T3 publication Critical patent/DK2300492T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK09762696.4T 2008-06-12 2009-06-10 Hidtil ukendt antiviralt peptid mod aviær influenza h9n2 DK2300492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20082061A MY160435A (en) 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2
PCT/MY2009/000071 WO2009151313A1 (en) 2008-06-12 2009-06-10 A novel antiviral peptide against avian influenza virus h9n2

Publications (1)

Publication Number Publication Date
DK2300492T3 true DK2300492T3 (da) 2014-09-01

Family

ID=41416902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09762696.4T DK2300492T3 (da) 2008-06-12 2009-06-10 Hidtil ukendt antiviralt peptid mod aviær influenza h9n2

Country Status (6)

Country Link
US (1) US8883480B2 (enExample)
EP (1) EP2300492B1 (enExample)
JP (1) JP5647111B2 (enExample)
DK (1) DK2300492T3 (enExample)
MY (1) MY160435A (enExample)
WO (1) WO2009151313A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013540425A (ja) * 2010-08-03 2013-11-07 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション インフルエンザ感染の治療および制限のうち少なくとも一方を行うためのポリペプチド
CN102830225B (zh) * 2012-09-24 2014-06-04 中国动物疫病预防控制中心 一种源于禽流感病毒自然弱毒株的血凝素和免疫抗原
MY184269A (en) * 2015-11-27 2021-03-30 Viramatix Sdn Bhd Broad-spectrum anti-influenza virus therapeutic peptides
KR20200012894A (ko) 2017-05-26 2020-02-05 비라매틱스 에스디엔 비에이치디 펩타이드 및 항바이러스제로서의 이의 용도
WO2020006494A1 (en) 2018-06-29 2020-01-02 Fred Hutchinson Cancer Research Center Cell-stored barcoded deep mutational scanning libraries and uses of the same
CN109487011B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h5、h7和h9以及9个na亚型aiv的引物组合及其应用
CN109487012B (zh) * 2019-01-07 2020-09-22 广西壮族自治区兽医研究所 用于检测9个na亚型aiv的引物组合及其应用
CN109628641B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h7以及5个na亚型aiv的引物组合及其应用
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
NZ506987A (en) * 1998-03-17 2003-01-31 Sangamo Biosciences Inc Nucleic acid binding proteins
WO2000059932A1 (fr) * 1999-03-31 2000-10-12 Otsuka Pharmaceutical Co., Ltd. Peptides se liant a l'hemagglutinine du virus de la grippe
WO2003006620A2 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US7888121B2 (en) * 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
WO2007022425A2 (en) * 2005-08-16 2007-02-22 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine
JP5093100B2 (ja) * 2006-03-13 2012-12-05 学校法人慶應義塾 インフルエンザ感染阻害ペプチド、インフルエンザウイルス感染阻害剤、リポソーム、インフルエンザ予防・治療剤
KR20090031938A (ko) * 2006-07-05 2009-03-30 더 스크립스 리서치 인스티튜트 방향성 진화로 촉매 작용을 최적화시킨 키메라 징크 핑거 리컴비나제
US8778847B2 (en) * 2007-06-13 2014-07-15 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic peptides of influenza virus
EP2174957B1 (en) * 2007-06-15 2016-03-16 Xiamen University Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof

Also Published As

Publication number Publication date
EP2300492B1 (en) 2014-06-04
JP2011522561A (ja) 2011-08-04
EP2300492A4 (en) 2012-03-14
MY160435A (en) 2017-03-15
JP5647111B2 (ja) 2014-12-24
US8883480B2 (en) 2014-11-11
EP2300492A1 (en) 2011-03-30
US20110135676A1 (en) 2011-06-09
WO2009151313A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
DK2300492T3 (da) Hidtil ukendt antiviralt peptid mod aviær influenza h9n2
BRPI0819191A2 (pt) uso de oligonucleotídeos com bases modificadas como agentes antivirais.
BRPI0908116A2 (pt) pulverizador
DK2280973T3 (da) Carbanukleosidanaloge til antiviral behandling
BRPI0911269A2 (pt) análogos de halicondrina b
DE112009005296A5 (de) Bedruckbare Beschichtung
EP2310144A4 (en) COATINGS
BRPI0906366A2 (pt) Inalador
HRP20180429T1 (hr) Raspršivač
BRPI0914817A2 (pt) inalador
EP2321062A4 (en) Sprayer
NO20083238L (no) Narresmokk
BRPI0910534A2 (pt) terapia antiviral
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
DK2308607T3 (da) Belægningsstruktur
ATE546999T1 (de) Feldspritze
BRPI0906779A2 (pt) Inalador
FI20086158A0 (fi) Imidatsopyridiinijohdannaiset
BRPI0922806A2 (pt) formas de dosagem oral de bendamustina
BRPI0909223A2 (pt) uso de catepsaina c
DK2277578T3 (da) Forstøver
BRPI1009826A2 (pt) revestimento antibioincrustação melhorado
BRPI0906369A2 (pt) Inalador
ATE549335T1 (de) Antivirale verbindungen
BR112012000805A2 (pt) revestimento mecanicamente estável